Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: The Italian expanded access program

E. Verzoni, G. Cartenì, E. Cortesi, D. Giannarelli, A. De Giglio, R. Sabbatini, S. Buti, S. Rossetti, F. Cognetti, F. Rastelli, A. Sobrero, D. Turci, C.N. Sternberg, C. Porta, F. Cappuzzo, G. Tortora, D. Tassinari, S. Panni, A. Pazzola, G. SuricoA. Raimondi, U. De Giorgi, G. Procopio

Research output: Contribution to journalArticle

Original languageUndefined/Unknown
JournalJournal for ImmunoTherapy of Cancer
Issue number1
Publication statusPublished - 2019

Cite this